Antiretroviral Therapy, Highly Active
"Antiretroviral Therapy, Highly Active" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drug regimens, for patients with HIV INFECTIONS, that aggressively suppress HIV replication. The regimens usually involve administration of three or more different drugs including a protease inhibitor.
| Descriptor ID |
D023241
|
| MeSH Number(s) |
E02.319.310.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Antiretroviral Therapy, Highly Active".
Below are MeSH descriptors whose meaning is more specific than "Antiretroviral Therapy, Highly Active".
This graph shows the total number of publications written about "Antiretroviral Therapy, Highly Active" by people in this website by year, and whether "Antiretroviral Therapy, Highly Active" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 0 | 1 | 1 |
| 2002 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2010 | 2 | 0 | 2 |
| 2011 | 3 | 2 | 5 |
| 2012 | 1 | 1 | 2 |
| 2013 | 1 | 1 | 2 |
| 2017 | 1 | 1 | 2 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Antiretroviral Therapy, Highly Active" by people in Profiles.
-
Population uptake of HIV testing, treatment, viral suppression, and male circumcision following a community-based intervention in Botswana (Ya Tsie/BCPP): a cluster-randomised trial. Lancet HIV. 2020 06; 7(6):e422-e433.
-
Pediatric Neurodevelopmental Functioning After In Utero Exposure to Triple-NRTI vs. Dual-NRTI + PI ART in a Randomized Trial, Botswana. J Acquir Immune Defic Syndr. 2018 11 01; 79(3):e93-e100.
-
Acute Care Management of the HIV-Infected Patient: A Report from the HIV Practice and Research Network of the American College of Clinical Pharmacy. Pharmacotherapy. 2017 May; 37(5):611-629.
-
Thirty-year Perspective of the Long-term Survival, CD4 Percentage and Social Achievements of Perinatally HIV-infected Children as a Function of Their Birth Era. Pediatr Infect Dis J. 2017 02; 36(2):198-201.
-
No clinically significant drug-resistance mutations in HIV-1 subtype C-infected women after discontinuation of NRTI-based or PI-based HAART for PMTCT in Botswana. J Acquir Immune Defic Syndr. 2013 Aug 15; 63(5):572-7.
-
Rational use of multiple medications in medicine and psychiatry: a dimensional perspective. J Psychiatr Pract. 2013 Jan; 19(1):54-61.
-
Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana. Antivir Ther. 2013; 18(4):585-90.
-
[Factors associated to late clinical stage at the initiation of antiretroviral therapy]. Medicina (B Aires). 2012; 72(5):367-70.
-
Loss of CD127 & increased immunosenescence of T cell subsets in HIV infected individuals. Indian J Med Res. 2011 Dec; 134(6):972-81.
-
Increased risk of preterm delivery among HIV-infected women randomized to protease versus nucleoside reverse transcriptase inhibitor-based HAART during pregnancy. J Infect Dis. 2011 Aug 15; 204(4):506-14.